title: Expression of type I and type II interleukin-1 receptors in mouse brain.
abstract: Although binding sites for IL-1 have been identified in the mouse brain, it is still unknown whether these binding sites correspond to the type I or type II IL-1 receptor. Quantitative autoradiography was used to confirm the presence of specific binding sites for radiolabelled recombinant human IL-1 alpha (125I-HuIL-1 alpha) in the brain of DBA/2 mice. IL-1 binding was highest in the dentate gyrus, consisting of a single class of high affinity binding sites with a Kd of 0.1 nM and a Bmax of 57 fmol/mg protein. A similar Kd of 0.2 nM was obtained using isolated membranes from the whole hippocampus, although the number of binding sites was lower (2 fmol/mg protein). Affinity cross-linking of 125I-Hu-IL-1 alpha to hippocampal membranes revealed the existence of two types of IL-1 receptor proteins, consistent with the sizes of the type I (85 kD) and type II (60 kD) IL-1 receptor. Oligonucleotide probes were then synthesized and used in RT-PCR followed by Southern blotting to show that the whole brain expresses transcripts for both the type I and type II IL-1 receptors. The murine neuroblastoma cell line, C1300, expresses type I rather than type II IL-1 receptor mRNA. The type I receptor protein can be identified by flow cytometry on the membrane of the C1300 neuronal cell line using indirect immunofluorescence with a rat anti-mouse type I IL-1 receptor MoAb. These data show that mouse brain expresses both type I and type II IL-1 receptor mRNA and proteins and offer further support to the idea that type I IL-1 receptors are synthesized and expressed by neurons.
authors.affiliation: INRA-INSERM, Laboratory of Integrative Neurobiology, Bordeaux, France.
authors.forename: P
authors.initials: P
authors.lastname: Parnet
authors.forename: S
authors.initials: S
authors.lastname: Amindari
authors.forename: C
authors.initials: C
authors.lastname: Wu
authors.forename: D
authors.initials: D
authors.lastname: Brunke-Reese
authors.forename: E
authors.initials: E
authors.lastname: Goujon
authors.forename: J A
authors.initials: JA
authors.lastname: Weyhenmeyer
authors.forename: R
authors.initials: R
authors.lastname: Dantzer
authors.forename: K W
authors.initials: KW
authors.lastname: Kelley
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D015139:Blotting, Southern; D001921:Brain / Q000378:metabolism*; D015870:Gene Expression; D006624:Hippocampus / Q000378:metabolism; D006801:Humans; D007375:Interleukin-1 / Q000378:metabolism; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D009363:Neoplasm Proteins / Q000096:biosynthesis / Q000235:genetics; D009419:Nerve Tissue Proteins / Q000096:biosynthesis* / Q000145:classification / Q000235:genetics; D009447:Neuroblastoma / Q000473:pathology; D016133:Polymerase Chain Reaction; D017472:Receptors, Interleukin-1 / Q000096:biosynthesis* / Q000145:classification / Q000235:genetics / Q000276:immunology; D011994:Recombinant Proteins / Q000378:metabolism; D014407:Tumor Cells, Cultured
chemical_list: D000911:Antibodies, Monoclonal; D007375:Interleukin-1; D009363:Neoplasm Proteins; D009419:Nerve Tissue Proteins; D017472:Receptors, Interleukin-1; D011994:Recombinant Proteins